- Report
- March 2024
Global
From €4335EUR$4,850USD£3,705GBP
- Report
- October 2024
- 266 Pages
Global
From €3575EUR$4,000USD£3,055GBP
- Report
- April 2023
- 111 Pages
Global
From €3575EUR$4,000USD£3,055GBP
- Report
- October 2021
- 166 Pages
Global
From €3575EUR$4,000USD£3,055GBP
- Report
- October 2021
- 260 Pages
Global
From €3575EUR$4,000USD£3,055GBP
From €3128EUR$3,500USD£2,673GBP
- Report
- July 2024
- 72 Pages
Global
From €3500EUR$4,195USD£3,096GBP
- Report
- July 2024
- 77 Pages
Global
From €3500EUR$4,195USD£3,096GBP
- Report
- July 2024
- 77 Pages
Global
From €3500EUR$4,195USD£3,096GBP
- Report
- January 2025
- 132 Pages
Global
From €849EUR$950USD£726GBP
- Report
- January 2025
- 132 Pages
Global
From €849EUR$950USD£726GBP
The Bioabsorbable Stent market is a subset of the larger Stent market. Bioabsorbable Stents are medical devices used to treat coronary artery disease. They are made of biodegradable materials that dissolve over time, allowing the artery to return to its natural state. This type of stent is advantageous over traditional metal stents, as it eliminates the need for a second procedure to remove the stent. Bioabsorbable Stents are also beneficial in that they reduce the risk of restenosis, a condition in which the artery becomes blocked again after stent placement.
Notable companies in the Bioabsorbable Stent market include Abbott, Biotronik, Elixir Medical, and Biosensors International. Show Less Read more